STOCK TITAN

Scholar Rock to Present at Upcoming Healthcare Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on serious diseases, announced its participation in several upcoming investor conferences. On November 9, it will present at the Credit Suisse Virtual Healthcare Conference, followed by the Cowen IO Next Virtual Summit on November 15. The company will also attend the Jefferies Global Healthcare Conference in London on November 17 and the Piper Sandler Virtual Healthcare Conference from November 30 to December 2. Webcasts of the presentations will be available on the company's website.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will participate in the following upcoming investor conferences:

  • Credit Suisse 30th Annual Virtual Healthcare Conference on Tuesday, November 9th, 2021 at 8:50 a.m. ET.
  • Cowen 5th Annual IO Next Virtual Summit on Monday, November 15th, 2021 at 8:15 a.m. ET.
  • 12th Annual Jefferies Global Healthcare Conference in London on Wednesday, November 17th, 2021 at 5:00 p.m. GMT (11:00 a.m. ET).
  • 33rd Annual Piper Sandler Virtual Healthcare Conference on November 30th-December 2nd, 2021. The webcast will be available beginning at 10:00 a.m. ET on November 22.

A live webcast of presentations at the Credit Suisse, Cowen and Jefferies conferences may be accessed by visiting the Investors & Media section of the Scholar Rock website at http://investors.scholarrock.com. All these webcasts will be archived and available on the Company’s website for approximately 90 days following the presentation.

About Scholar Rock

Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Scholar Rock is creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock’s approach to targeting the molecular mechanisms of growth factor activation enabled it to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at the cellular level. By developing product candidates that act in the disease microenvironment, the Company intends to avoid the historical challenges associated with inhibiting growth factors for therapeutic effect. Scholar Rock believes its focus on biologically validated growth factors may facilitate a more efficient development path. For more information, please visit www.ScholarRock.com or follow Scholar Rock on Twitter (@ScholarRock) and LinkedIn (https://www.linkedin.com/company/scholar-rock/).

Scholar Rock® is a registered trademark of Scholar Rock, Inc.

Scholar Rock:

Investors

Stephanie Ascher

Stern Investor Relations, Inc.

Stephanie.Ascher@sternir.com

212-362-1200

Media

Ariane Lovell

Finn Partners

ariane.lovell@finnpartners.com

917-565-2204

Source: Scholar Rock

FAQ

What events will Scholar Rock participate in November 2021?

Scholar Rock will participate in the Credit Suisse Virtual Healthcare Conference on November 9, Cowen IO Next Virtual Summit on November 15, Jefferies Global Healthcare Conference in London on November 17, and Piper Sandler Virtual Healthcare Conference from November 30 to December 2.

Where can I watch the Scholar Rock presentations?

The presentations can be accessed via live webcasts on the Investors & Media section of the Scholar Rock website.

What is the focus of Scholar Rock's research?

Scholar Rock focuses on discovering and developing innovative medicines for serious diseases that involve protein growth factors.

What is the ticker symbol for Scholar Rock?

The ticker symbol for Scholar Rock is SRRK.

How can I find more information about Scholar Rock?

More information about Scholar Rock can be found on their official website at www.ScholarRock.com.

Scholar Rock Holding Corporation

NASDAQ:SRRK

SRRK Rankings

SRRK Latest News

SRRK Stock Data

4.05B
91.72M
1.07%
98.55%
16.18%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE